CA2917358C — Therapeutically active compounds and their methods of use
Assigned to Les Laboratoires Servier SAS · Expires 2021-10-26 · 5y expired
What this patent protects
Compounds having Formula (Ia) and pharmaceutically acceptable salts and hydrates thereof are provided. The compounds and pharmaceutically acceptable salts and hydrates thereof are for use in the treatment of a cancer in a patient, the cancer characterized by the presence of an ID…
USPTO Abstract
Compounds having Formula (Ia) and pharmaceutically acceptable salts and hydrates thereof are provided. The compounds and pharmaceutically acceptable salts and hydrates thereof are for use in the treatment of a cancer in a patient, the cancer characterized by the presence of an IDH1 mutation. Methods of preparing these compounds are also provided.
Drugs covered by this patent
- Voranigo (VORASIDENIB) · Servier
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.